What is Intellia Therapeutics's PP&E (net)?

Intellia Therapeutics (NTLA) reported PP&E (net) of $15.52M in Q1 2026.

How has Intellia Therapeutics's PP&E (net) changed year-over-year?

Intellia Therapeutics's PP&E (net) decreased by 38.2% year-over-year, from $25.12M to $15.52M.

What is the long-term trend for Intellia Therapeutics's PP&E (net)?

Over 5 years (2020 to 2025), Intellia Therapeutics's PP&E (net) has grown at a 2.1% compound annual growth rate (CAGR), from $15.94M to $17.67M.

What does PP&E (net) mean?

Total property, plant, and equipment minus accumulated depreciation — the net book value of all tangible long-lived assets.

Intellia Therapeutics NTLA PP&E (Net)

PP&E (Net) at other companies

Ionis PharmaceuticalsIONS

$142.4M+38.4%

ALN

Alnylam PharmaceuticalsALNY

$518.26M+3.9%

CRISPR TherapeuticsCRSP

$112.18M-13.3%

Beam TherapeuticsBEAM

$101.25M-7.6%

Iovance Biotherapeutics, Inc.IOVA

$131.39M+17.8%

Viridian Therapeutics, Inc.VRDN

$1.13M-2.8%

Other financials

Income statement

See full

Revenue$15.0M-9.5%

Operating income-$100.5M+16.8%

Net income-$96.2M+15.8%

EPS (diluted)-$0.81+26.4%

Balance sheet

See full

Cash & equivalents$134.7M+6.2%

Total debt$80.5M-32.5%

Total equity$620.9M-20.4%

Total assets$758.8M-23.1%

Cash flow

See full

Operating cash flow-$117.3M+21.2%

CapEx$79.0K-89.3%

Free cash flow-$117.4M+21.5%

Valuation

See full

Market cap$2.17B+106%

Profitability

See full

Operating margin-636.6%-202pp

Net margin-597%-194pp

FCF margin-550.2%-140pp

Returns & leverage

See full

Return on equity-56.3%-1.5pp

Debt / equity0.1×0.0×

Current ratio6.1×+1.2×

Where this comes from

Reported directly by Intellia Therapeutics in its filing.

Tagged under the XBRL concept us-gaap:PropertyPlantAndEquipmentNet.

The official record: Intellia Therapeutics’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →

Ask your AI about Intellia Therapeutics's pp&e (net).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Intellia Therapeutics's PP&E (net)?: Intellia Therapeutics (NTLA) reported PP&E (net) of $15.52M in Q1 2026.
How has Intellia Therapeutics's PP&E (net) changed year-over-year?: Intellia Therapeutics's PP&E (net) decreased by 38.2% year-over-year, from $25.12M to $15.52M.
What is the long-term trend for Intellia Therapeutics's PP&E (net)?: Over 5 years (2020 to 2025), Intellia Therapeutics's PP&E (net) has grown at a 2.1% compound annual growth rate (CAGR), from $15.94M to $17.67M.
What does PP&E (net) mean?: Total property, plant, and equipment minus accumulated depreciation — the net book value of all tangible long-lived assets.